Trials / Sponsors / Claes-Göran Östenson
Claes-Göran Östenson
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes) Diabetes Type 2, Impaired Glucose Tolerance, Impaired Fasting Glucose | Phase 2 | 2013-10-01 |